195 related articles for article (PubMed ID: 11991672)
21. Effect of interleukin-18 on viral myocarditis: enhancement of interferon- gamma and natural killer cell activity.
Kanda T; Tanaka T; Sekiguchi K; Seta Y; Kurimoto M; Wilson McManus JE; Nagai R; Yang D; McManus BM; Kobayashi I
J Mol Cell Cardiol; 2000 Dec; 32(12):2163-71. PubMed ID: 11112992
[TBL] [Abstract][Full Text] [Related]
22. Effect of amrinone on murine viral myocarditis.
Seta Y; Kanda T; Yokoyama T; Kobayashi I; Suzuki T; Nagai R
Res Commun Mol Pathol Pharmacol; 1997 Jan; 95(1):57-66. PubMed ID: 9055349
[TBL] [Abstract][Full Text] [Related]
23. Treatment of experimental viral myocarditis with interleukin-10.
Nishio R; Matsumori A; Shioi T; Ishida H; Sasayama S
Circulation; 1999 Sep; 100(10):1102-8. PubMed ID: 10477536
[TBL] [Abstract][Full Text] [Related]
24. Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.
Nishio R; Shioi T; Sasayama S; Matsumori A
J Am Coll Cardiol; 2003 Jan; 41(2):340-5. PubMed ID: 12535832
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus.
Yamada T; Matsumori A; Sasayama S
Circulation; 1994 Feb; 89(2):846-51. PubMed ID: 8313574
[TBL] [Abstract][Full Text] [Related]
26. Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production.
Matsui S; Matsumori A; Matoba Y; Uchida A; Sasayama S
J Clin Invest; 1994 Sep; 94(3):1212-7. PubMed ID: 8083362
[TBL] [Abstract][Full Text] [Related]
27. Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury.
Suzuki H; Matsumori A; Matoba Y; Kyu BS; Tanaka A; Fujita J; Sasayama S
J Clin Invest; 1993 Jun; 91(6):2727-33. PubMed ID: 8390488
[TBL] [Abstract][Full Text] [Related]
28. Contribution of endothelin-1 to myocardial injury in a murine model of myocarditis: acute effects of bosentan, an endothelin receptor antagonist.
Ono K; Matsumori A; Shioi T; Furukawa Y; Sasayama S
Circulation; 1999 Oct; 100(17):1823-9. PubMed ID: 10534471
[TBL] [Abstract][Full Text] [Related]
29. Lessons from animal experiments in myocarditis.
Matsumori A
Herz; 1992 Apr; 17(2):107-11. PubMed ID: 1349548
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of myocardial damage and alteration of lymphocyte subsets in murine model of postpartum myocarditis.
Yokoyama T; Kanda T; Suzuki T; Murata K
Am J Cardiovasc Pathol; 1993; 4(4):343-51. PubMed ID: 8305197
[TBL] [Abstract][Full Text] [Related]
31. Pathogenesis of encephalomyocarditis experimental infection in young piglets: a potential animal model to study viral myocarditis.
Gelmetti D; Meroni A; Brocchi E; Koenen F; Cammarata G
Vet Res; 2006; 37(1):15-23. PubMed ID: 16336922
[TBL] [Abstract][Full Text] [Related]
32. [Effects of immunoglobulin on murine myocarditis caused by influenza A virus: experimental study].
Kishimoto C; Hiraoka Y; Takada H; Kurokawa M; Ochiai H
J Cardiol; 2005 Jun; 45(6):247-55. PubMed ID: 15991608
[TBL] [Abstract][Full Text] [Related]
33. Heat stress aggravates viral myocarditis in mice.
Kanda T; Nakano M; Yokoyama T; Hoshino Y; Okajima F; Tanaka T; Saito Y; Nagai R; Kobayashi I
Life Sci; 1999; 64(2):93-101. PubMed ID: 10069487
[TBL] [Abstract][Full Text] [Related]
34. An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis.
Tanaka A; Matsumori A; Wang W; Sasayama S
Circulation; 1994 Oct; 90(4):2051-5. PubMed ID: 7923693
[TBL] [Abstract][Full Text] [Related]
35. Increased severity of viral myocarditis in mice lacking lymphocyte maturation.
Kanda T; Koike H; Arai M; Wilson JE; Carthy CM; Yang D; McManus BM; Nagai R; Kobayashi I
Int J Cardiol; 1999 Jan; 68(1):13-22. PubMed ID: 10077396
[TBL] [Abstract][Full Text] [Related]
36. Relevance of inflammatory cell infiltrates for complete atrioventricular block in experimental murine myocarditis.
Kishimoto C; Ohmae M; Tomioka N
Cardiovasc Pathol; 2006; 15(3):139-43. PubMed ID: 16697926
[TBL] [Abstract][Full Text] [Related]
37. Oral administration of L-arginine prevents congestive heart failure in murine viral myocarditis.
Hiraoka Y; Kishimoto C; Takada H; Ochiai H
J Cardiovasc Pharmacol; 2002 Jul; 40(1):1-8. PubMed ID: 12072571
[TBL] [Abstract][Full Text] [Related]
38. Effects of naloxone, an opiate receptor antagonist, on coxsackievirus B3 myocarditis in the mouse.
Kishimoto C; Takada H; Hiraoka Y; Shiraki K
Cardiovasc Res; 1995 Jan; 29(1):80-4. PubMed ID: 7895243
[TBL] [Abstract][Full Text] [Related]
39. Role of interferon in the protective effect of an immunomodulator derived from the Su strain of Streptococcus pyogenes A3 against viral myocarditis in mice.
Kanda T; Yokoyama T; Suzuki T; Murata K
Arzneimittelforschung; 1993 Jan; 43(1):80-3. PubMed ID: 7680562
[TBL] [Abstract][Full Text] [Related]
40. Leptin deficiency enhances myocardial necrosis and lethality in a murine model of viral myocarditis.
Kanda T; Takahashi T; Kudo S; Takeda T; Tsugawa H; Takekoshi N
Life Sci; 2004 Aug; 75(12):1435-47. PubMed ID: 15240179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
